Tag | Content |
---|
EnhancerAtlas ID | HS076-00575 |
Organism | Homo sapiens |
Tissue/cell | H1 |
Coordinate | chr1:11967610-11970890 |
SNPs | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Nkx3-2 | MA0122.3 | chr1:11968331-11968344 | TTTAAGTGTTTTA | - | 6.33 | ZNF143 | MA0088.2 | chr1:11967995-11968011 | TACCCACAATGCATTG | + | 9.63 | ZNF143 | MA0088.2 | chr1:11970183-11970199 | CAATGCATTGTGGGTA | - | 9.63 | Zfx | MA0146.2 | chr1:11969285-11969299 | GAGGCCGAGGCGGG | - | 6.01 |
|
| Number of super-enhancer constituents: 23 | ID | Coordinate | Tissue/cell |
SE_04401 | chr1:11967802-11970392 | Brain_Anterior_Caudate | SE_05426 | chr1:11967459-11970702 | Brain_Cingulate_Gyrus | SE_06308 | chr1:11966827-11970789 | Brain_Hippocampus_Middle | SE_07453 | chr1:11967402-11970810 | Brain_Hippocampus_Middle_150 | SE_08423 | chr1:11967438-11970628 | Brain_Inferior_Temporal_Lobe | SE_10739 | chr1:11967490-11970531 | CD19_Primary | SE_13010 | chr1:11967686-11969397 | CD34_Primary_RO01480 | SE_13010 | chr1:11969509-11970356 | CD34_Primary_RO01480 | SE_13630 | chr1:11967645-11970731 | CD34_Primary_RO01536 | SE_14236 | chr1:11967710-11969205 | CD34_Primary_RO01549 | SE_14236 | chr1:11969377-11970343 | CD34_Primary_RO01549 | SE_14675 | chr1:11967367-11971255 | CD4_Memory_Primary_7pool | SE_16078 | chr1:11967699-11970381 | CD4_Naive_Primary_7pool | SE_16518 | chr1:11967714-11970388 | CD4_Naive_Primary_8pool | SE_21206 | chr1:11967365-11970416 | CD8_Memory_7pool | SE_21842 | chr1:11967413-11970668 | CD8_Naive_7pool | SE_22216 | chr1:11967346-11970790 | CD8_Naive_8pool | SE_34570 | chr1:11966817-11970548 | HCT-116 | SE_40308 | chr1:11967553-11971272 | K562 | SE_54351 | chr1:11967622-11970499 | Spleen | SE_66899 | chr1:11967081-11970418 | H2171 | SE_67244 | chr1:11967631-11970544 | MM1S | SE_67657 | chr1:11967812-11970390 | u87 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr1 | 11968510 | 11969143 | chr1 | 11967830 | 11968200 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH01I011910 | chr1 | 11970721 | 11971010 |
|
Enhancer Sequence | TTATGTTGCC CAGGCTGGTC TTGAACCCCT AGTTCAGGCG ATCAGCCTGC CTCAGCCACC 60 CAAAGTGCTG GGATTACAAG GGTGAGCCAC GGAGTCCAGC CAAGATAATT TTTTTTTTAC 120 TTTTTTTTTT AAGTTCAAAA AAATTCTTTA CTTATTAGGC TAATTGTGCA ATTAAAAAAA 180 AAAAAAAATT GCAAAAACCG CAATTACTTT TGCACCGATC TAATAGCTCG CCCACTGTAA 240 GTAAAGCAGG TAAAGTCAGC CTTTTTCTTC TGGGACCAGA CTCTGCTCTG CCCCGCGGTG 300 GTGGCCTCAG GCGCAGCGCT AAAACGCATG AACCATTTAA GGTATTTCCT GAAACTGGAG 360 CGTGATTGGT GAGACTTTAT TTGCATACCC ACAATGCATT GCGCACTAAA TAATGTTCGT 420 CTTTAAAATT ATTTCCCCTT TTTCCTTCAA CATATCTTTC TCGGAACCGA GATTGCTGTC 480 CCAGAATTGT CTGAAGAAAA AGGCTGAAGT CAATAGCTCT TTTGGGCCGA AGGAAAGTTA 540 CCATTACCCG TTTAGGAGTA GCCGTTACCT GAGAACTGTA GTGTCGACGA CTGATGTTAT 600 ACTCTGGTTT CTCTTCAAAT CGTATAAATC TTTCGCCTTT TACTAAAGAT TTCCGTGGAG 660 AGAAACGAGT GTGAGTCTGA AACCAATTTT TTGAGGCCTT GCGTTTCTTA GCAGGGCTTA 720 TTTTAAGTGT TTTAAAAACA GATGCGATTC CGTTAAATCG CGTGTGGAGC TATGTAAAGT 780 GTATTATAGA ACAAATGCGA GTTACGGTTT TTCAGCTTTT CGCTTTGTTA AGGTATGTGA 840 TATCAATTGT ATTGCATTTC TGAGCAGTTA TAATATTAAG ATGTTGGGGT GGCTTACTGC 900 TTTTGACCAA GAAGTAGGGT TTGTTGGTTG ATTACACCAG TGGTTTTTAA CCCCAGCCAC 960 TGAGTGATGG AGGGTTACCG ACTCACAAGC GAGCATTAAC GCCTGAGGTC CGCCTGCTGT 1020 CAGGGCAGCA AGGCATCAGA TTCTCCTAGG AGCGGGAACC CTATTGTGAA CTGCGTATAC 1080 GAGGTATCTA GGTGCGTGCT CCTTTTAAGA ATCTAATGGC TGATGACGAG GGGCACAGTT 1140 TCAACCTGGA ACTGTCCACA CCCCCTACCC ACCTTCCCCC GCCCTTGGAA AAACTGCCTT 1200 CCATGAACTG GGTCCCTTGT GCCAGAAAGG TTGGGGACCG CTGGACTATC CGATCAAATG 1260 AAGCAGGGAC TCGGGGCGAG CTCCCCCGCT GCTCCCGCCG GCTTCTCCGT GTAGAATCGA 1320 AGAAGGCAGT CCCAAGGGCT CTTCTGCCCC GTATCCCCGC CTGAGGAGCG TGCCAGGCGC 1380 GCAGCTAGTC CTCCCCCGAC CCAACCGGTT TGATGAAACG CAAGAGAAAG TGAATTTTCC 1440 AGCCACTCCC ATTGGCCAGA ATTCGTCTCA GCCGCAAGGG AGGCTGGGAA GTGCAGTCAT 1500 GCCTTCAGGT AGCCGTGAGC CCTGCTAGCG ATAGGAGATT CTAGAGAGAG GTTGAGTACT 1560 GGGGAGGAAA AACTAGCAGG GTCTGTCCCA GTAAAGGAGG GAGGAAATCC ATCGCAAAAA 1620 ATCCTGACCC CCAGGCCGGG CGCGGTGGCT CACGCCTGTA ATCCCAGCAC TTTGGGAGGC 1680 CGAGGCGGGC GGATCACCTG CGGATCACCT GAGGTCAGGA GTTCGAGACT GGCCTGGCCA 1740 ACATGGAGAA ACCCCGTCTC TACTAAAAAT ACAAAAATTA GCCGGGCAGG AGGGCGCATG 1800 CCTGTAATCA CAGCCACTCG GGAGGCTGAG GCAGGAGAAT CGCTTGAACC TGGAAGGCGG 1860 AGGTTGCAGT GAACCGAGAT CGCGCCACTG CACTCGATCC TGAGCGACAG AGCGAGACTC 1920 TGTCTCAAAA AAAAAAAAAA AAAAAAAAAA AAATCTACCC CGGGCTCAGG CCCTGAAGCA 1980 GCCGCCCACA GCCCAGCCCC GCCGTGCCCC GCCGTGCCCC GCCGTGCCCC GCCGTGCCCC 2040 GCCATGCGAC TCAAAGCCCC ATTCAAGCTA CGTAGGAGGG TAAATTGTCC TTTTCCCCCA 2100 AGGCCAGCTG CTCCTCCAGA AGCCAGCTCT GGTCCTTCAG ACTCAAATAC TAGGGAACAA 2160 TGTTTTCTCT GAGTTTTGAG TGTGTTTCTT GTTTCAGAGT AAATACGAAC CGTCGTAATG 2220 GCTAAGGGCA TCTACTTTTA AAACGCTCAA ATAAGCCTTG CTAAAAAATG CAAGACCTCT 2280 AAAAAATTGG TTTAAAACTC AGAATTATTC CTCTCCACGG AAATCTTTAG TAAAAGGCGA 2340 AAGATTTATG CGATATGAAG AGAAACTAGA GTAAGAACTT CGATGAGTGG CACTCAGTTC 2400 TCAGGTAATG GCTACTCCCA ACAGGCTAAT GGTAAATTTC TTTCTGCCCA AAAGAGCTAT 2460 TGACTTCTGC CTTTTTCTTC AGACAATTCT GGAACAGCAA TCTCAGTTTC AGGAAAGATA 2520 GATTGAAGGA AAAAGGGGAC TAGTAATTTT AAAGACGAAA ATTATTTGGT GCACAATGCA 2580 TTGTGGGTAT GCAAATAAAG TCTCAGCAAT CAAGCTCCAA TTTTGACAAA CTGGTGAAGC 2640 CTTAGGGACT CCTCAAAAAA AGGTTTTCTG TTGCTTTTGT TTTGTCTTAA ATTTCTGATT 2700 TTTAATGTTT GTGGGTACAT AGCATGTGTA TGTATGGGTT ACATGACAAG AGAAAGGTTT 2760 TGTTTGTTTG AGATGGAGTC TTGCTCTTGT CACCCAGGCT GGAGTGCTGT GGTGCGATCT 2820 CAGCTCACTG CAACCTCCGC CTCCTGGGTT CAAGCGATTC TCCTGCCTCA GCTTCCCGAG 2880 TAGCTGGGAT TACAGGTGTG AGCCACCATG CCCGGCTAAT TTTTGTATTT TTAGTAGAGA 2940 TGGGGTTTCA CCATGTTGGC CAGGCTGGTC TCGAACTCCT GACCTAAGGT GATCCGCCTG 3000 CCTCGGCCTC CCAAAGTGCT GGGATTACAG GCGTGAGCTA CTGCGCCCGG CCCCTGCGAA 3060 TGCTGTGTAG TTGTCTCTTC CCAAGGTTTT ATTCTGAGAG GAGCCCCAGC CTTTCTCACG 3120 AGCTCACTTG CCCAGTGTTG CCGTCTCCCA GGACAGCCAC AGAGCAGTCA CACTGGTCCC 3180 TGGCCCGGGT TTTCAGAGCT CTCCTCCACG TGTGTGTTAG GGTTCTCTAG AGGGACAGGA 3240 CCAATAGGAT CTACGTATAT ATGAGAGGGA CTTTATTAAG 3280
|